Important: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. GLP-1 receptor agonist medications require a prescription and medical supervision. Individual results vary. Consult a qualified healthcare provider to determine whether medical weight loss is appropriate for your specific situation.
Medical Weight Loss
YOU HAVEN'T FAILED AT WEIGHT LOSS
The tools you were given weren't enough. Here's what's different about medical weight loss.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · Updated March 25, 2026
Book a Weight Loss Evaluation
WHY DIETS FAIL
You already know the pattern. You start a diet. You're disciplined. You lose weight. Weeks or months later, the weight comes back. Sometimes more than you lost. You blame yourself. You decide you weren't committed enough, or disciplined enough, or that you just don't have the willpower other people seem to have.
That story is wrong. And the science has known it's wrong for over a decade.
When you restrict calories, your body doesn't just passively burn through its fat stores. It fights back. It treats the caloric deficit as a threat to survival and activates a coordinated set of hormonal and metabolic defenses designed to restore the weight you lost. This isn't a character flaw. It's physiology.
What happens after you lose weight through dieting:
The research: In 2016, researchers followed contestants from NBC's The Biggest Loser six years after the show. Despite dramatic weight loss during the competition, nearly all participants had regained most or all of the weight. The critical finding: their metabolic rates were still suppressed — burning 500+ fewer calories per day than expected for their body size. Their bodies were still fighting to regain the weight six years later. This wasn't a willpower failure. Their metabolisms had been permanently altered by the weight loss itself.
Fothergill E, et al. "Persistent metabolic adaptation 6 years after 'The Biggest Loser' competition." Obesity. 2016;24(8):1612-1619.
This is the part that no diet book tells you. The initial weight loss isn't the hard part. Your body allows the loss — temporarily. The hard part is the months and years after, when every hormonal system in your body is working to reverse what you did. You're not fighting calories. You're fighting a coordinated biological defense system that has been evolving for two million years.
And you were expected to beat it with a food journal and a Peloton.
THE SET-POINT THEORY
Your brain maintains a defended weight range — a set-point — that it will work to protect regardless of your conscious intentions. Think of it like a thermostat. You can open a window and temporarily cool a room, but the thermostat will keep running the furnace until the temperature returns to where it's set. Dieting is the open window. Your hypothalamus is the thermostat.
The set-point is regulated by a complex interplay of hormones — leptin, ghrelin, insulin, neuropeptide Y, and others — that communicate between your fat tissue, gut, and brain. When your weight drops below the set-point, these signals intensify: hunger increases, satiety decreases, metabolic rate slows, and food reward pathways in the brain become hyperactivated. You don't just want food more — food literally tastes better and provides more neurological reward when your body is trying to regain weight.
Here's the part that matters most: repeated cycles of weight loss and regain — yo-yo dieting — appear to ratchet the set-point upward over time. Each cycle may reset the defended range higher. The body learns from each dieting episode that famine is a recurring threat and adjusts its defenses accordingly. This means that for many people, the more diets they've tried, the harder the next one becomes. Not because of declining willpower. Because of ascending biology.
This is not a motivation problem. It is a neuroscience problem. And it explains why people who have "tried everything" — WW, keto, Noom, intermittent fasting, macro counting, 1,200-calorie meal plans — can follow each protocol with genuine discipline and still end up back where they started, or heavier. The tools were not proportional to the problem.
WHAT MEDICAL WEIGHT LOSS ACTUALLY IS
Medical weight loss is not "a diet with a doctor watching." It's not a meal plan with a prescription stapled to it. It's not a monthly telehealth call where someone asks if you've been drinking enough water.
Medical weight loss is pharmacology — the use of medications that directly address the hormonal and neurological systems that drive weight regain. The same systems that made every previous diet a temporary event.
When we talk about GLP-1 receptor agonist medications — semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) — we're talking about drugs that intervene at the level of the problem. They don't just reduce calories in. They change the hormonal signaling that controls hunger, satiety, food reward, and metabolic rate. They work with your biology instead of asking you to overpower it through force of will.
The distinction matters. Diets ask you to tolerate a caloric deficit while your body screams for food. GLP-1 medications reduce the screaming. They don't eliminate the need for good nutrition and movement. But they create a hormonal environment where those behaviors can actually produce lasting results — because your body is no longer mounting a full counterattack.
HOW GLP-1 MEDICATIONS WORK
GLP-1 (glucagon-like peptide-1) is a hormone your gut produces naturally after eating. It tells your brain you've had enough food, slows gastric emptying so you feel full longer, and regulates blood sugar. In people with obesity, this signaling system is often blunted — the message isn't getting through at full volume.
GLP-1 medications are synthetic versions of this hormone, engineered to last much longer than the natural version (which breaks down in minutes). A weekly injection maintains a steady level of GLP-1 receptor activation, producing effects that the body's own signaling can't sustain.
Semaglutide
Available Now
Activates the GLP-1 receptor. The STEP 1 trial showed average weight loss of 14.9% of body weight over 68 weeks. FDA-approved for weight management (as Wegovy) and type 2 diabetes (as Ozempic). The most-studied GLP-1 for weight loss, with cardiovascular risk reduction demonstrated in the SELECT trial.
Tirzepatide
Available Now
Activates both the GLP-1 and GIP receptors — a dual agonist. The SURMOUNT-1 trial showed average weight loss of 20.9% at the highest dose over 72 weeks. FDA-approved for weight management (as Zepbound) and type 2 diabetes (as Mounjaro). The addition of GIP appears to amplify metabolic effects beyond GLP-1 alone.
Retatrutide
In Clinical Trials — Not Yet Available
The next generation — a triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 data showed average weight loss of 24.2% at the highest dose over 48 weeks. Currently in Phase 3 trials (the TRIUMPH program). Not FDA-approved. If approved, it would add a third mechanism: the glucagon receptor increases energy expenditure and promotes liver fat burning. Read more about retatrutide.
These medications don't just suppress appetite. They reset the hunger and satiety signaling your body uses to defend the set-point. That's the difference between white-knuckling through a caloric deficit and actually having the biological support to sustain one. For many patients, the experience is described not as "forcing yourself to eat less" but as "the noise finally turning down" — the constant preoccupation with food, the intrusive thoughts about snacking, the feeling of never being truly satisfied after a meal. That quiets.
WHO'S A CANDIDATE
The clinical criteria are straightforward. FDA guidelines support GLP-1 medications for:
BMI of 30 or higher
With or without additional health conditions. A BMI of 30 represents clinical obesity and qualifies for pharmacotherapy on its own.
BMI of 27 or higher with a comorbidity
Such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease. The weight is contributing to a condition that carries its own health risks.
But beyond the numbers, there's a clinical reality that matters just as much: your history. If you have a sustained track record of genuine effort — real caloric restriction, structured programs, consistent exercise — without lasting results, that pattern is itself diagnostically meaningful. It tells us that the hormonal and metabolic drivers of your weight are stronger than what lifestyle intervention alone can overcome.
This distinction is important. Medical weight loss isn't for someone who hasn't tried. It's for someone who has tried — repeatedly, honestly, with real effort — and found that the results don't hold. That's not a character judgment. It's a clinical indicator that a different level of intervention is warranted.
If you're reading this article, you probably already know which category you fall into.
WHAT A REAL PROTOCOL LOOKS LIKE
The telehealth boom in GLP-1 prescribing has created a model where "medical weight loss" means a 15-minute video call, a prescription, and a monthly refill with no monitoring. That's not medicine. That's a vending machine with a co-pay.
A real medical weight loss protocol treats the full clinical picture, not just the prescription pad.
Comprehensive blood work
Metabolic panel, thyroid function, HbA1c, lipid panel, inflammatory markers. We need to understand what's driving your weight at the hormonal level before choosing a medication. We also need a safety baseline — liver function, kidney function, blood sugar — to monitor throughout treatment.
DEXA body composition scan
A scale tells you one number. A DEXA scan tells you exactly how much of your body is fat, how much is muscle, how much is bone, and where it's distributed. This becomes your real baseline — and the tool we use to make sure you're losing the right kind of weight throughout treatment.
Medication selection and titration
Based on your labs, body composition, medical history, and goals, we select the most appropriate medication and start at a low dose. Dosing increases gradually over weeks to minimize side effects and find the effective dose for your physiology. Not everyone needs the highest dose. Some do. The data tells us.
Protein targets and resistance training guidance
Medication without a muscle-preservation strategy is an incomplete protocol. We set protein targets (typically 0.7-1.0g per pound of body weight) and provide resistance training guidance to ensure you're preserving lean mass during weight loss. This is non-negotiable in a well-designed program.
Ongoing monitoring and adjustments
Regular check-ins. Follow-up labs. Repeat DEXA scans to verify you're losing fat, not muscle. Dose adjustments based on response. Management of side effects. This is an active medical relationship, not an auto-refill subscription.
The point: A prescription is a tool. A protocol is a plan. The difference between someone who loses 40 pounds and keeps it off versus someone who loses 40 pounds and regains 30 is rarely the medication itself — it's everything around the medication. The monitoring. The body composition tracking. The muscle preservation. The adjustments when something isn't working. That's what separates a clinic from an app.
THE MUSCLE PROBLEM
This is the part most weight loss programs — including many GLP-1 telehealth services — don't talk about. When you lose weight, you don't just lose fat. You lose muscle too. And how much muscle you lose changes everything about your long-term outcome.
In clinical trials, participants on GLP-1 medications typically lost 25-40% of their total weight loss as lean body mass (muscle, bone, water). That means if someone loses 40 pounds, 10-16 of those pounds may be muscle — not fat. On a scale, the number looks great. In your body, the consequences are significant.
Why muscle loss matters
- Muscle is the primary driver of your resting metabolic rate. Less muscle = fewer calories burned at rest = easier weight regain.
- Muscle loss contributes to the "skinny fat" phenomenon — a lower scale weight but unchanged body composition and health markers.
- Muscle is a metabolic organ. It regulates blood sugar, supports joint health, maintains bone density, and protects against falls and fractures as you age.
- Losing significant muscle during weight loss can leave you weaker and more metabolically fragile than before you started.
How we address it
- DEXA scans — Not guessing. Measuring. We track fat mass and lean mass separately so we can see exactly what you're losing and course-correct if the ratio shifts the wrong way.
- High protein intake — Protein provides the raw materials your muscles need to resist breakdown during a caloric deficit. We set specific daily targets and monitor adherence.
- Resistance training — The single most effective intervention for muscle preservation during weight loss. We provide structured guidance, not a generic "exercise more" recommendation.
The difference: Losing 30 pounds of pure fat while maintaining your muscle mass is a fundamentally different outcome than losing 20 pounds of fat and 10 pounds of muscle — even though the scale shows the same number. The first scenario leaves you leaner, stronger, and metabolically healthier. The second leaves you lighter but weaker, with a lower metabolic rate that makes regain more likely. A scale can't tell you which one is happening. A DEXA scan can.
COST & AFFORDABILITY
We're direct about pricing because we believe the lack of transparency in healthcare is itself a barrier to treatment.
Moonshot Medical Weight Loss Pricing
Price varies by medication and dose. Includes the medication itself, medical oversight, lab monitoring, DEXA body composition scans, and nutrition guidance. No hidden fees. No long-term contracts.
Is that a meaningful monthly expense? Yes. But consider the cost of not treating obesity — not in abstract terms, but in the specific, compounding costs that accumulate over years and decades:
Direct medical costs
- Type 2 diabetes medications: $200-900/month
- Blood pressure medications: $50-200/month
- Statin therapy for cholesterol: $50-300/month
- CPAP for sleep apnea: $150-300/month (rental)
- Knee or hip replacement: $30,000-60,000
- Cardiovascular event hospitalization: $50,000-200,000+
Indirect costs
- Reduced mobility and activity with your family
- Joint pain limiting daily function
- Fatigue affecting work performance
- Years of life lost to preventable cardiovascular disease
- Mental health burden of chronic weight cycling
- The accumulated cost of programs that didn't work
We're not suggesting that everyone with obesity will develop every complication on that list. We're saying that untreated obesity is a progressive condition with compounding risk, and the question isn't whether treatment costs money — it's whether the cost of treatment is less than the cost of the alternative. For most patients, the math is not close.
THE "CHEATING" QUESTION
You will encounter this. From friends, from family, from strangers on the internet, and possibly from your own internal dialogue. The implication that using medication for weight loss is "taking the easy way out" or "cheating."
Nobody calls blood pressure medication "cheating" at cardiovascular health. Nobody tells a person with hypothyroidism that taking levothyroxine is "the easy way out" of a slow metabolism. Nobody suggests that someone using an inhaler for asthma just isn't trying hard enough to breathe.
Obesity is a chronic, hormone-driven medical condition with genetic, neurological, and metabolic components. Treating it with medication that targets its underlying mechanisms is not cheating. It is medicine.
The stigma around weight loss medication persists because our culture still treats body weight as a moral issue rather than a medical one. That framing is not supported by the science. It is supported by the $72-billion diet industry, which profits directly from the belief that willpower alone should be sufficient — and that when it isn't, the appropriate response is to buy another diet book.
If someone questions your decision, you don't owe anyone an explanation. But if you want language: "I'm working with my doctor on a metabolic health protocol." That's it. It's accurate, it's clinical, and it doesn't invite debate.
FREQUENTLY ASKED QUESTIONS
Am I a candidate for medical weight loss?
Clinical guidelines support GLP-1 medication for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea). Beyond the numbers, if you've genuinely tried structured weight loss approaches without lasting results, that history is clinically meaningful. A medical evaluation — including blood work and body composition — helps us determine the right approach. Book an evaluation to find out.
Is GLP-1 medication safe?
Semaglutide and tirzepatide are FDA-approved medications with extensive clinical trial data supporting their safety and efficacy. The most common side effects are gastrointestinal — nausea, constipation, diarrhea — typically mild, mostly during dose escalation, and often resolving within weeks. The SELECT trial showed semaglutide reduces cardiovascular risk (heart attack, stroke) in people with obesity. At Moonshot, we monitor every patient with regular blood work and body composition tracking.
Will I gain the weight back if I stop the medication?
Clinical data shows that most patients regain a significant portion of weight after stopping GLP-1 medication — the STEP 1 extension showed roughly two-thirds regained within a year. This reflects the biological reality that obesity is a chronic condition, not a failure of the patient or the drug. Stopping blood pressure medication doesn't cure hypertension. Stopping GLP-1 therapy doesn't permanently reset your set-point. Many patients do best on long-term maintenance (sometimes at a lower dose). Others can taper off after building substantial muscle and establishing supportive habits — which is why we pair medication with resistance training and protein targets from day one.
How much does it cost?
$150-$405 per month at Moonshot Medical, depending on medication and dose. This includes the medication, medical oversight, labs, DEXA scans, and nutrition guidance. No hidden fees. No insurance games. We keep pricing transparent so cost is never a surprise. See full pricing details.
Do I need to exercise?
The medication will produce weight loss without exercise. But without resistance training, a meaningful portion of what you lose will be muscle — not just fat. Muscle loss slows your metabolism, weakens your body, and makes long-term maintenance harder. We strongly recommend resistance training (strength training, 2-4 sessions per week) and high protein intake to preserve lean mass. You don't need to be a gym person. You do need to give your muscles a reason to stick around while you're in a caloric deficit. We provide structured guidance to make this manageable.
References
- 1. Fothergill E, et al. "Persistent metabolic adaptation 6 years after 'The Biggest Loser' competition." Obesity. 2016;24(8):1612-1619.
- 2. Sumithran P, et al. "Long-term persistence of hormonal adaptations to weight loss." N Engl J Med. 2011;365(17):1597-1604.
- 3. Ravussin E, et al. "Reduced rate of energy expenditure as a risk factor for body-weight gain." N Engl J Med. 1988;318(8):467-472.
- 4. Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity." N Engl J Med. 2021;384:989-1002. (STEP 1)
- 5. Jastreboff AM, et al. "Tirzepatide once weekly for the treatment of obesity." N Engl J Med. 2022;387:205-216. (SURMOUNT-1)
- 6. Jastreboff AM, et al. "Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial." N Engl J Med. 2023;389(6):514-526.
- 7. Lincoff AM, et al. "Semaglutide and cardiovascular outcomes in obesity without heart failure." N Engl J Med. 2023;389:2221-2232. (SELECT)
- 8. Wilding JPH, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide." Diabetes Obes Metab. 2022;24(8):1553-1564. (STEP 1 extension)
YOU'VE TRIED ENOUGH ON YOUR OWN
The tools weren't enough. The biology was working against you. That chapter is done. Let's build a protocol that works with your body instead of against it — with real data, real monitoring, and medication that actually addresses the problem.